Skip to content

Extracellular Vesicles of MSCs Loaded Aloe Vera Hydrogel Combined with Fractional CO2 Laser to Treat Atrophic Acne Scars

Extracellular Vesicles of MSCs Loaded Aloe Vera Hydrogel Combined with Fractional CO2 Laser to Treat Atrophic Acne Scars

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083627
Enrollment
Unknown
Registered
2024-04-29
Start date
2024-04-30
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrophic Acne Scars

Interventions

Test group (fractional CO2 laser + extracellular vesicles of MSCs loaded aloe vera hydrogel):Patients receive fractional CO2 laser therapy every 4 weeks. Extracellular loaded aloe vera hydrogel will b
Control group 1 (fractional CO2 laser + aloe vera hydrogel):Patients receive fractional CO2 laser therapy every 4 weeks. Aloe vera hydrogel will be applied on the face every 3 days after each fraction
Control group 2 (fractional CO2 laser + hydrogel):Patients receive fractional CO2 laser therapy every 4 weeks. Hydrogel will be applied on the face every 3 days after each fractional CO2 laser therapy

Sponsors

South China Hospital of Shenzhen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: (1) 18 to 45 years old, without restriction of gender; (2) Diagnosed with facial atrophic acne scar; (3) Duration: 3 months to 10 years; (4) The patients could comply to the treatments and follow up schedule, without any other treatment for atrophic acne scar during the survey; (5) Informed consent should be signed.

Exclusion criteria

Exclusion criteria: (1) Photo sensitive skin or have taken photo sensitive medications within 1 month; (2) Exposure to sunlight within 1 month or might be exposed to sunlight within 1 month after treatments; (3) Have received facial tretinoin treatment, micro-invasive therapy, filler therapy, cosmetic surgery, ultraviolet therapy, intense pulse light therapy, laser treatment or radiofrequency treatment within 1 month; (4) Suffered from skin infection, wounds or insections that have not recovered; (5) Patients who were susceptible to hypertrophic scars or keloids; (6) Women who were pregnant or lactating; (7) Patients who were suffered from heart failure, renal failure, liver failure, or other severe fundamental diseases; (8) Patients who were suffered from immune deficiency or had suffered from cancer; (9) Patients suffered from psychological diseases or have unrealistic expectancy about treatment outcome.

Design outcomes

Primary

MeasureTime frame
VISIA skin analysis;Scar cosmesis assessment and rating, SCAR;Physiologic characteristics of skin;Scar types;DLQI (Dermatology Life Quality Index);ECCA grading scale;Global Aesthetic Improvement Scale (GAIS);Thrombin Time (TT) Test;

Secondary

MeasureTime frame
Semi-quantitative assessment of acute inflammatory reaction;

Countries

P.R. China

Contacts

Public ContactXianbiao Zou

South China Hospital of Shenzhen University

xbzou@126.com+86 138 1020 6326

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026